ADRENALIN 1 MG
EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG · DIN 00155357 · SEARCHLIGHT PHARMA INC
Health Canada status: MARKETED
What is ADRENALIN?
ADRENALIN 1 MG contains EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 00155357, held by SEARCHLIGHT PHARMA INC, supplied as SOLUTION for INTRAVENOUS ; SUBCUTANEOUS ; INTRASPINAL ; INTRAMUSCULAR ; INTRACARDIAC ; OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 24-May-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ADRENALIN used for?
The most common uses of epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity reactions to drugs and other allergens, and to prolong the action of infiltration anesthetics. Its cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is ADRENALIN called?
Also recorded in Canada as: EPIPEN (US), ADRENALINE (EU), EPIPEN (EU), ADRENALINE (UK), EPIPEN (UK), ADRENOR (IN), EPINEPHRINE (GLOBAL), EPINEPHRINE (US), Epinephrine auto-injector (GLOBAL), Adrenaline shot (GLOBAL).
Product details and regulatory record
| DIN | 00155357 |
|---|---|
| Brand name | ADRENALIN |
| Generic / active ingredient | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG |
| Manufacturer | SEARCHLIGHT PHARMA INC |
| Strength | 1 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS ; SUBCUTANEOUS ; INTRASPINAL ; INTRAMUSCULAR ; INTRACARDIAC ; OPHTHALMIC |
| Schedule | Ethical |
| ATC code | C01CA24 EPINEPHRINE |
| AHFS class | 12:12.12 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-May-2023 |
| Original market date | 1951-12-31 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 00155357 |
|---|---|
| DIN (unpadded, as printed on some documents) | 155357 |
| Brand name | ADRENALIN |
| Active ingredient / INN | EPINEPHRINE (EPINEPHRINE HYDROCHLORIDE) : 1 MG |
| ATC code | C01CA24 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C01 |
| AHFS class | 12:12.12 |
| Health Canada schedule | Ethical |
| Biosimilar biologic | No |
| Market authorization holder | SEARCHLIGHT PHARMA INC |
How is it stored and handled?
Protect from light and freezing. Store at room temperature between 15 and 30°C.
How is it supplied?
Ampoules: Each 1 mL ampoule. Vials: Each 30 mL vial.
Which pack is which?
| Strength on the label | 1 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS ; SUBCUTANEOUS ; INTRASPINAL ; INTRAMUSCULAR ; INTRACARDIAC ; OPHTHALMIC |
| Packaging as described in the monograph | Ampoules: Each 1 mL ampoule. Vials: Each 30 mL vial. |
| Storage | Protect from light and freezing. Store at room temperature between 15 and 30°C. |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Is EPINEPHRINE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by PFIZER CANADA ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C01CA24 EPINEPHRINE. 7 of 29 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| EPINEPHRINE INJECTION | 1 MG / 10 ML | SOLUTION | LABORATOIRE AGUETTANT | MARKETED | DIN 02521148 |
| EPINEPHRINE INJECTION USP | 1 MG / 1 ML | SOLUTION | HIKMA CANADA LIMITED | MARKETED | DIN 02435810 |
| EPINEPHRINE INJECTION USP | 1 MG / 10 ML | SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 00710814 |
| EPINEPHRINE INJECTION USP | Strength | Solution | PFIZER CANADA ULC 17300 Trans-Canada Highway Kirkland Quebec Canada H9J 2M5 | MARKETED | DIN 00721891 |
| EPIPEN | 0.3 MG / 0.3 ML | SOLUTION | MYLAN SPECIALTY LP | MARKETED | DIN 00509558 |
| EPIPEN JR | 0.15 MG / 0.3 ML | SOLUTION | MYLAN SPECIALTY LP | MARKETED | DIN 00578657 |
| ADRENACLICK 0.15MG AUTO-INJECTOR | 0.15 MG / 0.15 ML | SOLUTION | AMEDRA PHARMACEUTICALS LLC | CANCELLED PRE MARKET | DIN 02354322 |
| ADRENACLICK 0.30MG AUTO-INJECTOR | 0.30 MG / 0.30 ML | SOLUTION | AMEDRA PHARMACEUTICALS LLC | CANCELLED PRE MARKET | DIN 02354330 |
| ALLERJECT | 0.15 MG / 0.15 ML | SOLUTION | VALEO PHARMA INC | CANCELLED POST MARKET | DIN 02382059 |
| ALLERJECT | 0.3 MG / 0.3 ML | SOLUTION | VALEO PHARMA INC | CANCELLED POST MARKET | DIN 02382067 |
How much does EPINEPHRINE cost around the world?
EPINEPHRINE is listed on 6 national price registers Nexara tracks, across 32 pack listings published on 6 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| United States | acquisition | 3 | 13 | 03 Sep 2026 |
| Saudi Arabia | public | 7 | 7 | 01 Sep 2026 |
| Morocco | PPV (public price) | 3 | 6 | 05 Sep 2026 |
| Greece | producer price (ex-factory) | 4 | 4 | 03 Sep 2026 |
| Bahrain | retail (max) | 1 | 1 | 01 Sep 2026 |
| South Africa | single exit price | 1 | 1 | 01 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.